MHAT Dr Stefan Cherkezov
Veliko Tarnovo, Bulgaria
Hospital in Veliko Tarnovo
ul. "Nish" 1, 5002 Rayon Zapaden, Veliko Tarnovo
About MHAT Dr Stefan Cherkezov
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
4
Bayer
3
Galapagos NV
3
Pfizer
3
Boehringer Ingelheim
2
R-Pharm International, LLC
2
Biota Scientific Management Pty Ltd
1
Clinical Trials at MHAT Dr Stefan Cherkezov
During the past decade, MHAT Dr Stefan Cherkezov conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 9 clinical trials were completed, i.e. on
average, 56.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis
2007-02-05
2017-10-26
Completed
4,488
Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza
2013-05-01
2014-05-01
Completed
639
BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis
2015-01-26
2016-10-18
Completed
645
Long-term Assessment of Safety and Efficacy of BI 695501 in Patients With Rheumatoid Arthritis
2016-01-22
2017-11-01
Completed
430
Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
2016-05-24
2019-11-05
Completed
1,648
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
2017-02-23
2026-09-01
Active, not recruiting
1,173
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
2016-10-31
2022-11-11
Completed
1,374
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
2017-03-17
2025-01-01
Enrolling by invitation
1,000
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MHAT Dr Stefan Cherkezov" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Bayer" with 3 trials
sponsored, "Galapagos NV" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Boehringer Ingelheim"
with 3 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MHAT Dr Stefan Cherkezov"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at MHAT Dr Stefan Cherkezov
According to Clinical.Site data, the most researched conditions in "MHAT Dr Stefan Cherkezov" are
"Arthritis, Rheumatoid" (3 trials), "COVID-19" (2 trials), "Crohn's Disease" (2 trials), "Heart Failure" (2 trials) and "Influenza A" (2 trials). Many other conditions were trialed in "MHAT Dr Stefan Cherkezov" in a lesser frequency.
Clinical Trials Intervention Types at MHAT Dr Stefan Cherkezov
Most popular intervention types in "MHAT Dr Stefan Cherkezov" are "Drug" (18 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (10 trials), "Filgotinib" (3 trials), "BI 695501" (2 trials), "PF-07321332" (2 trials) and "Pimodivir 600 mg" (2 trials). Other intervention names were less common.
Clinical Trials Genders at MHAT Dr Stefan Cherkezov
The vast majority of trials in "MHAT Dr Stefan Cherkezov" are
18 trials for "All" genders.
Clinical Trials Status at MHAT Dr Stefan Cherkezov
Currently, there are NaN active trials in "MHAT Dr Stefan Cherkezov".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 9 completed trials in MHAT Dr Stefan Cherkezov,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in MHAT Dr Stefan Cherkezov, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".